Tradestie Institutional Equity Comparison Engine

HHS vs DLX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DLX Overall Edge

DLX Captures Institutional Edge (4โ€“0 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Deluxe Corporation (DLX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, HHS trades at 14.3x Forward P/E with -3.2% operating margin (-1.7% YoY revenue) versus DLX at 6.5x Forward P/E and 12.8% operating margin (+2.5% YoY). In options structure, HHS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DLX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner DLX
HHS 14.3x vs DLX 6.5x Fwd P/E
Growth & Margin Winner DLX
Op Margin -3.2% vs 12.8% ยท YoY -1.7% vs +2.5%
Momentum & Technical Winner DLX
1Y +8.8% vs +32.3% ยท 52W Pos 69% vs 63%
Options & Structure Winner DLX
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (<1st %ile IV)
HHS US Equity
Harte Hanks, Inc.
Services-Direct Mail Advertising Services
$3.84
-4.24% 1D
Market Cap $30.0M
1M Return -10.49%
1Y Return +8.78%
Forward P/E 14.3x
Unified AI Score
61.8 / 100 BUY
Tech 76.0 Fund 61.0 Flow 50.0 Mom 54.0
DLX NYSE
Deluxe Corporation
Blankbooks, Looseleaf Binders & Bookbindg & Relatd Work
$27.05
+1.01% 1D
Market Cap $1.2B
1M Return +16.7%
1Y Return +32.34%
Forward P/E 6.5x
Unified AI Score
31.4 / 100 SELL
Tech 50.0 Fund 28.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: HHS +8.78% DLX +32.34% Spread: +2.4 pp (HHS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
HHS TTM Op. Margin: -3.2% DLX TTM Op. Margin: 12.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HHS vs DLX. Trailing 12-month operating profitability (HHS -3.2% vs DLX 12.8%) and valuation multiples (HHS 14.3x vs DLX 6.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: HHS (4) vs DLX (6)
Institutional Metric HHS DLX Criterion Row Winner
Market Capitalization Scale $30.0M $1.2B Larger Scale DLX
Trailing P/E Ratio Valuation 14.3x 15.5x Lower Multiple HHS
Forward P/E Ratio Valuation 14.3x 6.5x Lower Multiple DLX
Revenue Growth (YoY) Growth -1.7% +2.5% Higher Growth DLX
Operating Margin (TTM) Profitability -3.2% 12.8% Higher Margin DLX
Net Profit Margin Profitability -3.7% 3.8% Higher Margin DLX
Return on Equity (ROE) Capital Efficiency -30.4% 11.6% Higher ROE DLX
52-Week Range Position Momentum 69% ($2โ€“$5) 63% ($19โ€“$32) Stronger Trend HHS
Beta / 30D Volatility Risk Regime 0.49ฮฒ ยท 46% Vol -0.45ฮฒ ยท 75% Vol Lower Realized Risk HHS
Unified Institutional Score Composite Signal 61.8 / 100 (BUY) 31.4 / 100 (SELL) Higher Composite HHS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full HHS vs DLX Buy Guide
HHS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live HHS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DLX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live DLX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither HHS nor DLX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.